DOI: 10.12890/2022_003553

A Rare Case of Longitudinally Extensive Transverse Myelitis Following Pfizer-BioNTech COVID-19 Vaccination with a Favourable Outcome

Authors

  • Ojbindra KC Department of Hospital Medicine, Faith Regional Health Services, Norfolk, Nebraska, USA
  • Punya Hari Dahal Department of Hospital Medicine, Faith Regional Health Services, Norfolk, Nebraska, USA
  • Manisha Koirala Department of Hospital Medicine, Faith Regional Health Services, Norfolk, Nebraska, USA
  • Sumeet Kumar Yadav Department of Hospital Medicine, Mayo Clinic Health System, Mankato, Minnesota, USA

ojbindra@gmail.com

Keywords

COVID-19, transverse myelitis, mRNA COVID-19 vaccines, autoimmune disease

Abstract

Introduction: mRNA COVID-19 vaccines are very safe, but rare adverse events such as transverse myelitis have been reported after COVID-19 vaccination.

Case Description: We report the case of 50-year-old man who presented with progressive lower extremity weakness, back pain and urinary retention after his second dose of the Pfizer COVID-19 vaccine. MRI of the spine revealed longitudinally extensive transverse myelitis (LETM). He recovered completely after treatment with intravenous methylprednisone and physical therapy. 

Discussion: This case highlights the rare association between LETM and COVID-19 vaccines and encourages clinicians to maintain a high index of suspicion for prompt diagnosis and treatment.

View the entire article

Downloads

References

  1. Kitley JL, Leite MI, George JS, Palace JA. The differential diagnosis of longitudinally extensive transverse myelitis. Mult Scler J 2012;18(3):271–285.
  2. Trebst C, Raab P, Voss EV, Rommer P, Abu-Mugheisib M, Zettl UK, et al. Longitudinal extensive transverse myelitis—it's not all neuromyelitis optica. Nat Rev Neurol 2011;7:688–698.
  3. Baxter R, Lewis E, Goddard K, Fireman B, Bakshi N, DeStefano F, et al. Acute demyelinating events following vaccines: a case-centered analysis. Clin Infect Dis 2016;63:1456–1462.
  4. Goss AL, Samudralwar RD, Das RR, Nath A. ANA investigates: neurological complications of COVID-19 vaccines. Ann Neurol 2021;89(5):856–857.
  5. Bhat A, Naguwa S, Cheema G, Gershwin ME. The epidemiology of transverse myelitis. Autoimmun Rev 2010;9(5):A395–A399.
  6. Agmon-Levin N, Kivity S, Szyper-Kravitz M, Shoenfeld Y. Transverse myelitis and vaccines: a multi-analysis. Lupus 2009;18(13):1198–1204.
  7. Hsiao YT, Tsai MJ, Chen YH, Hsu CF. Acute transverse myelitis after COVID-19 vaccination. Medicina 2021;57(10):1010.
  8. Zanoni G, Nguyen TM, Destefani E, Masala L, Nardelli E, Tridente G. Transverse myelitis after vaccination. Eur J Neurol 2002;9:696–697.
  9. Vojdani A, Kharrazian D. Potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases. Clin Immunol 2020;217:108480.
  10. Gao JJ, Tseng HP, Lin CL, Shiu JS, Lee MH, Liu CH. Acute transverse myelitis following COVID-19 vaccination. Vaccines (Basel) 2021;9(9):1008.
  11. Alabkal J, Rebchuk AD, Lyndon D, Randhawa N. Incomplete subacute transverse myelitis following vaccination with Pfizer-BioNTech COVID-19 mRNA vaccine: a case report. Cureus 2021;13(12):e20460.
  12. Hirose S, Hara M, Koda K, Natori N, Yokota Y, Ninomiya S,et al. Acute autoimmune transverse myelitis following COVID-19 vaccination: a case report. Medicine (Baltimore) 2021;100(51):e28423.
  13. Fernandes J, Jaggernauth S, Ramnarine V, Mohammed SR, Khan C, Panday A. Neurological conditions following COVID-19 vaccinations: chance or association? Cureus 2022;14(2): e21919.
  14. Miyaue N, Yoshida A, Yamanishi Y, Tada S, Ando R, Hosokawa Y, Yabe H, Nagai M. A case of refractory longitudinally extensive transverse myelitis after severe acute respiratory syndrome oronavirus 2 vaccination in a japanese man. Intern Med 2022;61(5):739-742.
  15. Khan E, Shrestha AK, Colantonio MA et al. Acute transverse myelitis following SARS-CoV-2 vaccination: a case report and review of literature. J Neurol 2022;269:1121–1132.
  16. Fitzsimmons W, Nance CS. Sudden onset of myelitis after COVID-19 vaccination: an under-recognized severe rare adverse event. Available at SSRN 3841558. 2021 May 5. doi.org/10.2139/ssrn.3841558
  17. McLean P, Trefts L. Transverse myelitis 48 hours after the administration of an mRNA COVID 19 vaccine. Neuroimmunology Reports 2021;1:100019.
  18. Nakano H, Yamaguchi K, Kawabata K, Asakawa M, Matsumoto Y. Acute transverse myelitis after BNT162b2 vaccination against COVID-19: Report of a fatal case and review of the literature. J Neurol Sci 2022;434:120102.
  19. Eom H, Kim SW, Kim M, Kim YE, Kim JH, Shin HY, Lee HL. Case reports of acute transverse myelitis associated with mRNA vaccine for COVID-19. J Korean Med Sci 2022;37(7):e52.
  20. Albokhari AA, Alsawas A, Adnan MH, Alasmari A, Aljuhani S, Almejalli M, Kedah H. Acute inflammatory transverse myelitis post-Pfizer-BioNTech-COVID-19 vaccine in 16-year-old. JMRI 2021;5:1-4. doi: 10.25259/JMRI_25_2021

Published

2022-09-15

Issue

Vol. 9 No. 9 (2022)

Categories

How to Cite

1.
KC O, Dahal PH, Koirala M, Yadav SK. A Rare Case of Longitudinally Extensive Transverse Myelitis Following Pfizer-BioNTech COVID-19 Vaccination with a Favourable Outcome. EJCRIM [Internet]. 2022 Sep. 15 [cited 2026 Nov. 3];9(9). Available from: https://ejcrim.com/index.php/ejcrim/article/view/3553